# Qiang Lü

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/qiang-lu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,135 |
| Field | Diabetes, Cardiovascular Risks, and Lipoproteins |
| h-index | 26 |
| i10-index | 82 |
| Last Known Institution | Deciphera Pharmaceuticals (United States) |
| OpenAlex ID | https://openalex.org/A5073143460 |
| ORCID iD | 0009-0001-9287-8333 |
| Works | 270 |

## Researcher papers

- [Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)](https://scholariq.org/papers/tislelizumab-combined-with-chemotherapy-as-neoadjuvant-therapy-for-surgically/)
- [Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF](https://scholariq.org/papers/cause-of-death-and-predictors-of-all-cause-mortality-in-anticoagulated-patients/)
- [Anti-NMDAR encephalitis](https://scholariq.org/papers/anti-nmdar-encephalitis/)
- [Depression, anxiety and quality of life in parents of children with epilepsy](https://scholariq.org/papers/depression-anxiety-and-quality-of-life-in-parents-of-children-with-epilepsy/)
- [Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial](https://scholariq.org/papers/safety-and-effectiveness-of-metformin-plus-lifestyle-intervention-compared-with/)
- [Association between chronic diseases and depression in the middle-aged and older adult Chinese population—a seven-year follow-up study based on CHARLS](https://scholariq.org/papers/association-between-chronic-diseases-and-depression-in-the-middle-aged-and-older/)
- [How to simplify the diagnostic criteria of hypertension in adolescents](https://scholariq.org/papers/how-to-simplify-the-diagnostic-criteria-of-hypertension-in-adolescents/)
- [Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects](https://scholariq.org/papers/pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-dupilumab-in/)
- [Limbic Encephalitis Associated with Anti-γ-aminobutyric Acid B Receptor Antibodies](https://scholariq.org/papers/limbic-encephalitis-associated-with-anti-aminobutyric-acid-b-receptor-antibodies/)
- [Differential Binding of Sarilumab and Tocilizumab to IL‐6Rα and Effects of Receptor Occupancy on Clinical Parameters](https://scholariq.org/papers/differential-binding-of-sarilumab-and-tocilizumab-to-il-6r-and-effects-of/)
- [Dry Eye and Phacoemulsification Cataract Surgery: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/dry-eye-and-phacoemulsification-cataract-surgery-a-systematic-review-and-meta/)

## Researcher topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Obesity, Physical Activity, Diet](https://scholariq.org/topics/obesity-physical-activity-diet/)
- [Autoimmune Neurological Disorders and Treatments](https://scholariq.org/topics/autoimmune-neurological-disorders-and-treatments/)
- [Lipid metabolism and disorders](https://scholariq.org/topics/lipid-metabolism-and-disorders/)

## Researcher university

- [Deciphera Pharmaceuticals (United States)](https://scholariq.org/institutions/deciphera-pharmaceuticals-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.